Nanovis completes $5.5M funding round to meet spinal implant demands: 3 details

Mackenzie Garrity -   Print  |

Nanovis generated $5.5 million during a funding round managed by Commenda Securities.

Here are three details:

1. The funds will go towards efforts to meet increased working capital and sales needs after seeing demands from surgeons and distributors for the nanotechnology-enhanced spinal implants.

2. Nanovis' FortiCore interbodies comprise porous, interconnected titanium scaffolds. The interbodies also feature a nanotube surface and are intermolded with a PEEK core.

3. Top investors included Elevate Ventures, 1st Source Capital Corp., Purdue's Foundry Investment Fund, Commenda Capital and Ellipsis Ventures.

More articles on surface technology:
4 things to know about Emerging Implant Technologies
Titanium fiber plates show potential for bone repair: 3 study insights
5 risk factors for cage migration and cage retropulsion after TLIF

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers